Greenwich LifeSciences Ownership | Who Owns Greenwich LifeSciences?
Greenwich LifeSciences Ownership Summary
Greenwich LifeSciences is owned by 8.81% institutional investors, 52.93% insiders, and 38.26% retail investors. Blackrock is the largest institutional shareholder, holding 2.40% of GLSI shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.17% of its assets in Greenwich LifeSciences shares.
GLSI Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Greenwich LifeSciences | 8.81% | 52.93% | 38.26% |
Sector | Healthcare Stocks | 49.73% | 8.84% | 41.43% |
Industry | Biotech Stocks | 47.04% | 8.74% | 44.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Blackrock | 308.91K | 2.40% | $5.33M |
Vanguard group | 268.17K | 2.09% | $4.63M |
Geode capital management | 127.69K | 0.99% | $2.20M |
Credit agricole s a | 87.00K | 0.68% | $1.50M |
State street | 68.40K | 0.53% | $1.18M |
Renaissance | 36.90K | 0.29% | $636.89K |
Northern trust | 24.32K | 0.19% | $419.76K |
Charles schwab investment management | 18.45K | 0.14% | $318.52K |
Bank of new york mellon | 15.29K | 0.12% | $263.99K |
Morgan stanley | 7.05K | 0.05% | $121.73K |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Credit agricole s a | 87.00K | 0.01% | $1.50M |
Founders capital management | 500.00 | 0.01% | $8.63K |
Renaissance | 36.90K | 0.00% | $636.89K |
Corebridge financial | 3.21K | 0.00% | $55.47K |
Washington trust advisors | 200.00 | 0.00% | $3.45K |
Strs ohio | 4.80K | 0.00% | $82.85K |
Ameritas investment partners | 585.00 | 0.00% | $10.10K |
Geode capital management | 127.69K | 0.00% | $2.20M |
New york state common retirement fund | 6.00K | 0.00% | $104.00K |
Blackrock | 308.91K | 0.00% | $5.33M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Blackrock | 308.91K | 0.00% | 252.45K |
Credit agricole s a | 87.00K | 0.01% | 87.00K |
Geode capital management | 127.69K | 0.00% | 69.44K |
State street | 68.40K | 0.00% | 55.40K |
Vanguard group | 268.17K | 0.00% | 45.07K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Millennium management | - | - | -63.81K |
Goldman sachs group | - | - | -41.51K |
Susquehanna group, llp | - | - | -35.87K |
Jane street group | - | - | -20.64K |
Qube research | - | - | -17.32K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Credit agricole s a | 87.00K | 0.01% | 87.00K | $1.50M |
Charles schwab investment management | 18.45K | 0.00% | 18.45K | $318.52K |
Bank of new york mellon | 15.29K | 0.00% | 15.29K | $263.99K |
Rhumbline advisers | 6.80K | 0.00% | 6.80K | $117.34K |
New york state common retirement fund | 6.00K | 0.00% | 6.00K | $104.00K |
Sold Out
Holder | Change |
---|---|
Old point trust & financial services n a | -100.00 |
Macquarie group | -110.00 |
Game plan financial advisors | -200.00 |
Tower research capital llc (trc) | -530.00 |
Newbridge financial services group | -1.90K |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Sep 30, 2024 | 38 | 15.15% | 1,157,959 | 13.42% | 8 | 13.98% | 21 | -16.00% | 7 | 133.33% |
Jun 30, 2024 | 33 | 13.79% | 1,020,904 | 58.33% | 7 | 31.52% | 25 | 56.25% | 3 | -25.00% |
Mar 31, 2024 | 29 | 11.54% | 644,803 | 20.31% | 5 | 28.84% | 16 | 6.67% | 4 | - |
Dec 31, 2023 | 26 | 13.04% | 535,932 | -0.26% | 4 | 23.85% | 15 | 150.00% | 4 | -50.00% |
Sep 30, 2023 | 23 | - | 537,344 | -14.54% | 4 | 17.46% | 6 | -40.00% | 8 | 14.29% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard Total Stock Mkt Idx Inv | 153.46K | 1.17% | - |
iShares Russell 2000 ETF | 141.70K | 1.08% | -322.00 |
PV BUYBACK USA Classe B USD | 87.00K | 0.66% | - |
Vanguard Institutional Extnd Mkt Idx Tr | 71.31K | 0.54% | - |
Fidelity Small Cap Index | 61.70K | 0.47% | -1.12K |
iShares Russell 2000 Growth ETF | 50.66K | 0.39% | - |
Fidelity Extended Market Index | 33.19K | 0.25% | 1.94K |
State St Russell Sm Cap® Indx SL Cl I | 28.50K | 0.22% | - |
Vanguard Russell 2000 ETF | 27.21K | 0.21% | -170.00 |
NT R2000 Index Fund - NL | 14.61K | 0.11% | 14.61K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Nov 21, 2024 | Thompson Jaye | VP Clinical Reg Affairs | Buy | $12.91K |
Sep 26, 2024 | Patel Snehal | CEO and CFO | Buy | $21.95K |
Aug 12, 2024 | Thompson Jaye | VP Clinical Reg Affairs | Buy | $11.08K |
Aug 06, 2024 | Patel Snehal | CEO and CFO | Buy | $27.62K |
Aug 05, 2024 | Patel Snehal | CEO and CFO | Buy | $72.49K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q3 | 5 | - |
2024 Q2 | 2 | - |
2024 Q1 | 6 | - |
2023 Q4 | 7 | - |
2023 Q3 | 7 | - |
GLSI Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools